Evaluation of Transcranial Photobiomodulation in Autism Spectrum Disorder

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

February 11, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Autism Spectrum Disorder
Interventions
DEVICE

Transcranial Photobiomodulation (tPBM)

"Transcranial Photobiomodulation (tPBM) is a novel treatment approach based on application of an invisible, non-ionizing electromagnetic wave that results in metabolic modulation in tissues targeted. This intervention consists of exposing bilaterally the frontal brain to the electromagnetic wave that penetrates the skin and skull into brain tissue, is non-invasive and minimally dissipated as thermal energy.~Other Names:~Niraxx G1 Headband"

DEVICE

Placebo/ Sham

The sham treatment will consist of applying all the procedures for the delivery of tPBM, but will not deliver light.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER